1. Home
  2. IMOS vs PRTA Comparison

IMOS vs PRTA Comparison

Compare IMOS & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMOS
  • PRTA
  • Stock Information
  • Founded
  • IMOS 1997
  • PRTA 2012
  • Country
  • IMOS Taiwan
  • PRTA Ireland
  • Employees
  • IMOS N/A
  • PRTA N/A
  • Industry
  • IMOS Semiconductors
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMOS Technology
  • PRTA Health Care
  • Exchange
  • IMOS Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • IMOS 679.2M
  • PRTA 643.0M
  • IPO Year
  • IMOS N/A
  • PRTA N/A
  • Fundamental
  • Price
  • IMOS $18.49
  • PRTA $13.77
  • Analyst Decision
  • IMOS
  • PRTA Buy
  • Analyst Count
  • IMOS 0
  • PRTA 7
  • Target Price
  • IMOS N/A
  • PRTA $46.50
  • AVG Volume (30 Days)
  • IMOS 24.0K
  • PRTA 711.1K
  • Earning Date
  • IMOS 02-20-2025
  • PRTA 02-13-2025
  • Dividend Yield
  • IMOS 6.10%
  • PRTA N/A
  • EPS Growth
  • IMOS 7.03
  • PRTA N/A
  • EPS
  • IMOS 0.07
  • PRTA N/A
  • Revenue
  • IMOS $724,842,895.00
  • PRTA $133,350,000.00
  • Revenue This Year
  • IMOS $11.63
  • PRTA $56.89
  • Revenue Next Year
  • IMOS $6.29
  • PRTA N/A
  • P/E Ratio
  • IMOS $12.75
  • PRTA N/A
  • Revenue Growth
  • IMOS 13.31
  • PRTA N/A
  • 52 Week Low
  • IMOS $17.70
  • PRTA $11.70
  • 52 Week High
  • IMOS $32.19
  • PRTA $34.75
  • Technical
  • Relative Strength Index (RSI)
  • IMOS 44.05
  • PRTA 48.19
  • Support Level
  • IMOS $17.70
  • PRTA $12.39
  • Resistance Level
  • IMOS $18.60
  • PRTA $13.64
  • Average True Range (ATR)
  • IMOS 0.34
  • PRTA 1.03
  • MACD
  • IMOS 0.01
  • PRTA -0.02
  • Stochastic Oscillator
  • IMOS 51.97
  • PRTA 40.47

About IMOS ChipMOS TECHNOLOGIES INC.

ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. The Company derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Share on Social Networks: